Ex parte WARD - Page 2




                     Appeal No. 1997-3322                                                                                                                                                
                     Application No. 08/353,940                                                                                                                                          


                                Claims 1 and 31 are illustrative of the claims on appeal and read as follow:                                                                             

                                1.   A cloning vector which expresses and secretes V  or V  T-cell receptor variable "        $                                                          
                     domain in a gram-negative cell, said secretion being into the bacterial periplasm or into a                                                                         
                     culture medium, said vector comprising the following elements in the 5' to 3' direction, said                                                                       
                     elements which are operatively linked:                                                                                                                              
                                (a) an inducible promoter DNA sequence;                                                                                                                  
                                (b) a leader sequence; and                                                                                                                               
                                (c) a DNA sequence encoding a V  or V  T-cell receptor variable domain."        $                                                                                        
                                31.        A method for expressing and secreting a T-cell receptor variable domain in                                                                    
                     a gram-negative bacterium, comprising the steps:                                                                                                                    
                                a)         culturing a gram-negative bacterium transformed with a vector, said                                                                           
                                vector comprising the following elements in the 5' to 3' direction, said                                                                                 
                                elements which are operatively linked:                                                                                                                   
                                           i)         a lacZ inducible promoter DNA sequence;                                                                                            
                                           ii)        a leader sequence selected from the group consisting of pelB,                                                                      
                                                      ompA and phoA; and                                                                                                                 
                                           iii)       a DNA sequence encoding at least one of a V  or V  T-cell receptor        "        $                                               
                                                      variable domain; and                                                                                                               
                                b)         adding about 0.1 to 1 mM of isopropylthiogalactopyranoside;                                                                                   
                                           to produce a T-cell receptor variable domain.                                                                                                 

                                The prior art references of record relied upon by the examiner in rejecting the                                                                          
                     appealed claims are:                                                                                                                                                
                     Novotny et al. (Novotny 1986), “Secondary, tertiary, and quaternary structure of T-cell-                                                                            
                     specific immunoglobulin-like polypeptide chains,” Proc. Natl. Acad. Sci. USA, Vol. 83, pp.                                                                          
                     742-46 (1986).                                                                                                                                                      
                     Skerra et al. (Skerra), “Assembly of a Functional Immunoglobulin F  Fragment in                                                                                     
                                                                                                                                 v                                                       
                     Escherichia coli,” Science, Vol. 245, pp. 1040-41 (1988).                                                                                                           
                     Novotny et al. (Novotny 1991), “Assoluble, dingle-chain T-cell receptor fragment endowed                                                                            
                     with antigen-combining properties,” Proc. Natl. Acad. Sci USA, Vol. 88,                                                                                             
                     pp. 8646-650 (1991).                                                                                                                                                

                                                                                           2                                                                                             





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007